IL1B and rheumatoid arthritis: This mechanism modulates inflammatory and apoptotic responses in chondrocytes, resulting in reduced inflammation and catabolism, and decreased secretion of IL-6, IL-1β, TNF-α, and PGE2, ultimately mitigating cartilage degeneration in OA and RA [82,83].